Novartis Q2 Adj. EPS $2.41 Beats $2.13 Estimate, Sales $14.408B Beat $14.042B Estimate
Novartis (NYSE:NVS) reported quarterly earnings of $2.41 per share which beat the analyst consensus estimate of $2.13 by 13.15 percent. This is a 0.41 percent decrease over earnings of $2.42 per share from the same
Novartis made more money per share than experts predicted, showing the company is running well. When a company beats expectations, it's a sign things are going better than people thought.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.